Recap: Biolase Q2 Earnings - Benzinga


Biolase BIOL reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.


Biolase missed estimated earnings by 46.77%, reporting an EPS of $-0.91 versus an estimate of $-0.62.

Revenue was up $3.10 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.09 which was followed by a 16.67% increase in the share price the next day.

Here’s a look at Biolase’s past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.68   -0.75 -1
EPS Actual -0.77 -0.75 -0.50 -0.5
Revenue Estimate 9.01M 11.97M 8.78M 8.31M
Revenue Actual 10.17M 12.41M 9.53M 9.13M

To track all earnings releases for Biolase visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Image and article originally from Read the original article here.